David A. Iruegas-Nunez

Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension

Víctor Segura-Ibarra, Javier Amione‐Guerra, A.S. Cruz-Solbes et al. · International Journal of Pharmaceutics · 2017 · 35 citations

Pharmacy, Pharmaceutics, Pharmacotherapy +16

COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey

Diego Ramonfaur, David E. Hinojosa-González, Gloria Paulina Rodriguez-Gomez et al. · Revista Panamericana de Salud Pública · 2021 · 32 citations · Full text

Medicine, Population Health Sciences, Preventive Medicine +17

Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention

Víctor Segura-Ibarra, Francisca E. Cara, Suhong Wu et al. · Journal of Controlled Release · 2017 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol

Sergio Fragoso-Saavedra, David A. Iruegas-Nunez, Alejandro Quintero-Villegas et al. · BMC Infectious Diseases · 2020 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14